Ergo Science (Ergo Science) Cash-to-Debt : 13.31 (As of Sep. 2006)

View and export this data going back to . Start your Free Trial

What is Ergo Science Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Ergo Science's cash to debt ratio for the quarter that ended in Sep. 2006 was 13.31.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Ergo Science could pay off its debt using the cash in hand for the quarter that ended in Sep. 2006.

The historical rank and industry rank for Ergo Science's Cash-to-Debt or its related term are showing as below:

ERGN's Cash-to-Debt is not ranked ^*
in the Business Services industry.
Industry Median: 0.975
* Ranked among companies with meaningful Cash-to-Debt only.

Ergo Science Cash-to-Debt Historical Data

The historical data trend for Ergo Science's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Ergo Science Cash-to-Debt Chart

Ergo Science Annual Data

Trend

Dec96

Dec97

Dec98

Dec99

Dec00

Dec01

Dec02

Dec03

Dec04

Dec05

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

4.01

17.92

Ergo Science Quarterly Data
	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06
Cash-to-Debt	Get a 7-Day Free Trial															No Debt	17.92	No Debt	13.83	13.31

Competitive Comparison of Ergo Science's Cash-to-Debt

For the Staffing & Employment Services subindustry, Ergo Science's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ergo Science's Cash-to-Debt Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Ergo Science's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Ergo Science's Cash-to-Debt falls into.

Ergo Science Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Ergo Science's Cash to Debt Ratio for the fiscal year that ended in Dec. 2005 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	7.22	/	(0.403	+	0)
	=	17.92

Ergo Science's Cash to Debt Ratio for the quarter that ended in Sep. 2006 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.644	/	(0.424	+	0)
	=	13.31

Ergo Science (GREY:ERGN) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Ergo Science Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Ergo Science's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Ergo Science (Ergo Science) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Ergo Science Corp (GREY:ERGN) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

402 Office Park Drive, Suite 260, Birmingham, AL, USA, 35223

Website

http://www.ergoscience.com

Ergo Science Corp is a United States based workforce injury prevention and treatment provider. It is focused on employee safety and employer risk reduction. The company offers physical abilities tests built from defensible, peer-reviewed research; evidence-based injury prevention and rehabilitation for diversified businesses.

Executives

Citigroup Inc	director	388 GREENWICH STREET, NEW YORK NY 10013
Iticorp	director	399 PARK AVENUE, NEW YORK NY 10043
Citicorp Banking Corp	director	ONE PENNS WAY, NEW CASTLE DE 19720
Citigroup Holdings Co	director	336 THE STRAND, LONDON ENGLAND
Court Square Capital Ltd	director	399 PARK AVE, NEW YORK NY 10043

Ergo Science (Ergo Science) Headlines

No Headlines